RSV Disease in the Elderly

计划入组 1,401 人 · 首次发布于 2005 年 10 月 30 日

RESCEU: Defining the Burden of RSV Disease

计划入组 2,000 人 · 首次发布于 2018 年 10 月 5 日

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

计划入组 6,635 人 · 首次发布于 2005 年 8 月 12 日

RSV vaccine

DPX-RSV

RSV-001

RSV Therapeutics LLC

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

Sanofi Ships Beyfortus in US to Protect Infants Against RSV

Sanofi Ships Beyfortus® in the U.S. to Protect Infants Against RSV

EMA Committee Recommends Expanding GSK's RSV Vaccine to All Adults 18 and Over